(Q83521129)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Target-selective drug delivery through liposomes labeled with oligobranched neurotensin peptides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Jlenia Brunetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Diego Tesauro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Alessandro Pini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Luisa Bracci

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Antonella Accardo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Barbara Lelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Giancarlo Morelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

2 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

678-685

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats

24 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Methods for Intracellular Delivery of Quantum Dots

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Liposomes with entrapped doxorubicin exhibit extended blood residence times

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Antibody-modified liposomes for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Antibody-targeted liposomes in cancer therapy and imaging

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Targeted tumor diagnosis and therapy with peptide hormones as radiopharmaceuticals

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Targeting cytotoxic conjugates of somatostatin, luteinizing hormone-releasing hormone and bombesin to cancers expressing their receptors: a "smarter" chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Design, synthesis and preclinical evaluation of radiolabeled peptides for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

The Vps10p-domain receptor family.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Modular branched neurotensin peptides for tumor target tracing and receptor-mediated therapy: a proof-of-concept.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Structural and relaxometric characterization of peptide aggregates containing gadolinium complexes as potential selective contrast agents in MRI

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Liposomal doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000463

7 January 2021

Identifiers

DOI

10.1002/CMDC.201000463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21370475%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference